🚨 70 pounds. That's the average weight loss adults with obesity saw on the highest dose of an investigational once-weekly Lilly medicine in a new Phase 3 study over 18 months. Nearly 2 in 3 people on the highest dose no longer met the BMI criteria for obesity by the end of the study. Still in clinical trials, but this is a meaningful step toward the potential to treat obesity and its related health conditions. See our press release at the link in bio. #ADA2026